Cargando…
Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?
During the last decade, many studies have demonstrated the role of CMV specific T-cell immune response on controlling CMV replication and dissemination. In fact, it is well established that transplanted patients lacking CMV-specific T-cell immunity have an increased occurrence of CMV replication epi...
Autores principales: | García-Ríos, Estéfani, Nuévalos, Marcos, Mancebo, Francisco J., Pérez-Romero, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104120/ https://www.ncbi.nlm.nih.gov/pubmed/33968058 http://dx.doi.org/10.3389/fimmu.2021.657144 |
Ejemplares similares
-
Outpatient Antimicrobial Stewardship Intervention Targeting Cytomegalovirus (CMV) Viremia in Solid Organ Transplant (SOT) Recipients
por: Wang, Nan, et al.
Publicado: (2017) -
1597. Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus (CMV) Infection and Disease in Solid Organ Transplant (SOT) Recipients
por: Khurana, Mark Poulsen, et al.
Publicado: (2018) -
Deciphering the Potential Coding of Human Cytomegalovirus: New Predicted Transmembrane Proteome
por: Mancebo, Francisco J., et al.
Publicado: (2022) -
COVID-19 in SOT versus non-SOT
por: Allam, Sridhar R., et al.
Publicado: (2021) -
CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies
por: Smith, Corinne J., et al.
Publicado: (2016)